Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Senda Biosciences is raising $123,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Guillaume Pfefer played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Orna Therapeutics is raising $221,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Thomas Barnes played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Modulate is raising $30,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Michael Pappas played a key…
Cambridge, Massachusetts — Seqirus, Inc. has been awarded a $69,672,000.00 federal contract with the Department of Health and Human Services (HHS); Office of Assistant Secretary for Preparedness and Response. to provide services to the federal…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Empatica is raising $33,949,997.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Matteo Lai played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Quantori is raising $15,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Richard Golob played…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Cognito Therapeutics is raising $126,175,917.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Brent Vaughan played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, VistaPath Biosystems is raising $7,416,436.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Timothy Spong played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Atlantic Quantum is raising $9,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Bharath Kannan played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Abata Therapeutics is raising $95,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Samantha Singer…